RxDoctor Payments Data

Stephen Lockey

Orthopaedic Surgery of the Spine · Charlottesville, VANPI 1144756552

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (42.2%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Alphatec Spine, Inc at 42.9% of the total. 2025 is the largest year on record at $13,996, 2.4 times the $5,819 reported in 2023.

$26,916in general payments, 2019–2025

Across 103 payments — averaging $261.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alphatec Spine, Inc$12K
  • Globus Medical$9K
  • Medtronic$4K
  • Boston Scientific$546
  • Arteriocyte Medical Systems, Inc.$514
  • Cerapedics Inc.$336
  • plus $788 from 7 others

What the payments were for

  • Consulting fees$9,68836%
  • Travel & lodging$11,36942%
  • Food & beverage$5,85922%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,916 in reported general payments places this provider in the 65th percentile of 43 orthopaedic surgery of the spine providers in Virginia.

See all orthopaedic surgery of the spine providers in Virginia

Medicare billing

Part B allowed, 2024
$152,662
Medicare patients
321
Services billed
705

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib18$547
Cyclobenzaprine Hcl23$101
Meloxicam15$43
Tramadol Hcl13$21

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Charlottesville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →